Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

ULTRAGENYX PHARMACEUTICAL INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Equity

Common stock, $0.001 par value per share

Rule 456(b) and Rule 457(r) (2)

(2)

(2)

(2)

(1)

(1)

Equity

Preferred stock, $0.001 par value per share

Rule 456(b) and Rule 457(r) (2)

(2)

(2)

(2)

(1)

(1)

Debt

Debt securities

Rule 456(b) and Rule 457(r) (2)

(2)

(2)

(2)

(1)

(1)

Other

Warrants

Rule 456(b) and Rule 457(r) (2)

(2)

(2)

(2)

(1)

(1)

Other

Units (3)

Rule 456(b) and Rule 457(r) (2)

(2)

(2)

(2)

(1)

(1)

Equity

Common stock, $0.001 par value per share

Rule 457(o)

N/A

N/A

$350,000,000

0.0001476

$51,660.00

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Total Offering Amounts

$350,000,000

$51,660.00

Total Fees Previously Paid

N/A

Total Fee Offsets

N/A

Net Fee Due

$51,660.00

(1) The registrant is deferring payment of the registration fee pursuant to Rule 456(b) under the Securities Act of 1933, as amended (the “Securities Act”) and is excluding this information in reliance on Rule 456(b) and Rule 457(r) under the Securities Act. Any additional registration fees will be paid subsequently on a pay-as-you-go basis.

(2) The registrant is registering hereby an indeterminate initial offering price and number or amount of securities of each identified class of securities as may from time to time be sold at indeterminate prices.

(3) Any securities registered hereunder may be sold separately or as units with other securities registered hereunder.